Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPTNYSE:INFUNASDAQ:SMLRNASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$11.89-1.6%$12.80$5.11▼$19.22$332.79M1.03235,726 shs172,203 shsINFUInfuSystem$5.41-6.7%$5.30$4.61▼$9.97$113.70M1.7393,988 shs175,434 shsSMLRSemler Scientific$44.32-1.4%$35.99$21.77▼$81.56$494.26M1.33491,216 shs1.15 million shsTMCITreace Medical Concepts$5.88-3.6%$7.23$4.54▼$10.79$369.79M0.79608,420 shs400,460 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro-1.57%-9.79%-10.64%-28.89%+96.20%INFUInfuSystem-6.72%-12.03%+8.20%-29.28%-27.96%SMLRSemler Scientific-1.36%+8.41%+29.29%-7.16%+89.81%TMCITreace Medical Concepts-3.61%-12.50%-8.51%-37.25%+10.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLPTClearPoint Neuro1.6684 of 5 stars3.52.00.00.02.20.00.6INFUInfuSystem2.454 of 5 stars2.00.00.00.03.04.21.9SMLRSemler Scientific2.5454 of 5 stars3.51.00.00.02.62.51.3TMCITreace Medical Concepts2.2709 of 5 stars3.11.00.00.02.34.20.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLPTClearPoint Neuro 3.00Buy$25.00110.26% UpsideINFUInfuSystem 4.00Strong Buy$13.00140.30% UpsideSMLRSemler Scientific 3.00Buy$71.0060.20% UpsideTMCITreace Medical Concepts 2.29Hold$10.1672.74% UpsideCurrent Analyst Ratings BreakdownLatest INFU, SMLR, TMCI, and CLPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025TMCITreace Medical ConceptsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.605/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/11/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$9.50 ➝ $8.004/1/2025CLPTClearPoint NeuroStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $25.003/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/13/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $9.503/3/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$8.40 ➝ $10.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$31.39M10.60N/AN/A$0.86 per share13.83INFUInfuSystem$137.58M0.83$0.42 per share12.79$2.47 per share2.19SMLRSemler Scientific$56.29M8.78$2.61 per share16.95$10.45 per share4.24TMCITreace Medical Concepts$210.82M1.75N/AN/A$2.24 per share2.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$22.09M-$0.76N/AN/AN/A-59.64%-62.10%-38.39%8/6/2025 (Estimated)INFUInfuSystem$870K$0.1490.1817.45N/A1.12%2.78%1.41%N/ASMLRSemler Scientific$20.58M-$2.619.03∞N/A72.65%50.77%47.04%8/4/2025 (Estimated)TMCITreace Medical Concepts-$49.53M-$0.85N/AN/AN/A-30.33%-51.12%-26.36%8/5/2025 (Estimated)Latest INFU, SMLR, TMCI, and CLPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025CLPTClearPoint Neuro-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million5/8/2025Q1 2025TMCITreace Medical Concepts-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million2/26/2025Q4 2024CLPTClearPoint Neuro-$0.15-$0.20-$0.05-$0.20$8.23 million$7.77 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint NeuroN/A4.543.61INFUInfuSystem0.501.981.59SMLRSemler ScientificN/A3.143.09TMCITreace Medical Concepts0.514.122.98Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%INFUInfuSystem71.13%SMLRSemler Scientific49.37%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.97%INFUInfuSystem11.40%SMLRSemler Scientific30.20%TMCITreace Medical Concepts27.72%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11027.99 million25.90 millionOptionableINFUInfuSystem41021.02 million19.10 millionOptionableSMLRSemler Scientific12011.15 million6.47 millionNot OptionableTMCITreace Medical Concepts25062.89 million47.08 millionOptionableINFU, SMLR, TMCI, and CLPT HeadlinesRecent News About These CompaniesTMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors – Lead Plaintiff Deadline June 10, 2025May 23 at 6:30 PM | accessnewswire.comTMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action LawsuitMay 23 at 6:09 PM | globenewswire.comClass Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 DeadlineMay 23 at 5:15 PM | accessnewswire.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCIMay 23 at 5:00 PM | accessnewswire.comInvestors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025May 23 at 1:15 PM | accessnewswire.comInvestor Alert: Deadline Approaching to Join Treace Medical Concepts, Inc. (TMCI) Class Action - Contact Levi & KorsinskyMay 23 at 12:15 PM | accessnewswire.comTreace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMay 23 at 12:00 PM | prnewswire.comSecurities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025May 23 at 11:06 AM | accessnewswire.comTMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLPMay 23 at 10:20 AM | globenewswire.comClass Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 DeadlineMay 23 at 7:15 AM | accessnewswire.comTMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!May 23 at 7:00 AM | accessnewswire.comShareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class Action - TMCIMay 23 at 5:45 AM | prnewswire.comInvestors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights – Contact Levi & Korsinsky Before June 10, 2025May 22 at 4:45 PM | accessnewswire.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCIMay 22 at 4:44 PM | globenewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCIMay 22 at 4:30 PM | accessnewswire.comLevi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 – TMCIMay 22 at 1:31 PM | globenewswire.comContact Levi & Korsinsky by June 10, 2025 to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)May 22 at 1:15 PM | accessnewswire.comSecurities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky Before June 10, 2025May 22 at 11:30 AM | accessnewswire.comLost Money on Treace Medical Concepts, Inc. (TMCI)? Contact Levi & Korsinsky to Join Class Action Before June 10, 2025May 22 at 7:15 AM | accessnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ:TMCI)May 22 at 7:00 AM | accessnewswire.comBalyasny Asset Management L.P. Has $87,000 Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)May 21 at 3:36 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINFU, SMLR, TMCI, and CLPT Company DescriptionsClearPoint Neuro NASDAQ:CLPT$11.89 -0.19 (-1.57%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$11.90 +0.01 (+0.08%) As of 05/23/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.InfuSystem NYSE:INFU$5.41 -0.39 (-6.72%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.44 +0.03 (+0.55%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Semler Scientific NASDAQ:SMLR$44.32 -0.61 (-1.36%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$43.92 -0.40 (-0.89%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.Treace Medical Concepts NASDAQ:TMCI$5.88 -0.22 (-3.61%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.88 0.00 (0.00%) As of 05/23/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
